Cancer of the lymphatic system
Malignant lymphomas arise from transformed cells of the lymphatic system. Most patients with lymphomas present with lymphnode swellings. Accounting for about 12% of all childhood cancers and showing an incidence of 210 newly diagnosed young patients per year, malignant lymphomas are the third most frequent malignancy in German children and teenagers. Two major groups of lymphomas can be differentiated: Hodgkin Lymphomas (Morbus Hodgkin) and Non Hodgkin Lymphomas (NHL). Since they usually affect the whole organism, they belong to the group of systemic diseases.

You will find our information on Hodgkin-Lymphoma and current treatment concepts here:

• » Summary

You will find our information on Non-Hodgkin-Lymphomas and current treatment concepts here:

Almost all European
children and teenagers with malignant lymphomas are treated according to standardised, continuously optimised protocols based on clinical trials. Currently active trials:

ALCL 99: NHL ALCL 99: NHL ALCL-Relapse: NHL B-NHL BFM 04: NHL B-NHL BFM Rituximab EuroNet-PHL-C1: M. Hodgkin EuroNet-PHL-LP1: M. Hodgkin

Treatment guidelines, follow-up plans, reports on clinical trials and additional related information:

M. Hodgkin guidelines M. Hodgkin guidelines NHL guidelines Guidelines aftercare Reports on clinical trials Follow-up plans Checklists OncoWorkStation

you will find a selection of additional information on malignant lymphomas provided by external sources here:

Competence Net Lymphomas Competence Net Lymphomas Nat. Cancer Inst. / Hodgkin L. Nat. Cancer Inst. / NHL Cancer Information Service (Krebsinformationsdie...